English
  • Notice: Undefined variable: sectorLink in Drupal\five_paisa\Controller\StockDetailController->getSectorLink() (line 450 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'stockName' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'NSEcode' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  • Warning: array_column() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 33 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_multisort(): Argument #1 is expected to be an array or a sort flag in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 34 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_slice() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 36 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: Invalid argument supplied for foreach() in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 52 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Notice: Undefined index: open_price in Drupal\five_paisa\StockService::openPrevData() (line 3918 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: prev_close in Drupal\five_paisa\StockService::openPrevData() (line 3919 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: vol in Drupal\five_paisa\StockService::openPrevData() (line 3923 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: fiftytwo_low in Drupal\five_paisa\StockService::fiftyLowHighData() (line 3901 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: fiftytwo_high in Drupal\five_paisa\StockService::fiftyLowHighData() (line 3902 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: day_low in Drupal\five_paisa\StockService::dayLowData() (line 3884 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: day_high in Drupal\five_paisa\StockService::dayLowData() (line 3885 of modules/custom/five_paisa/src/StockService.php).
  1. Home
  2. Stocks
  3. Pharmaid Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Pharmaids Pharmaceuticals

    Small Cap
    ₹50.00
    +0.49 (0.99%)
    01 July, 2024 06:45 BSE: 524572 NSE: PHARMAIDISIN: INE117D01018

    Start SIP in Pharmaids Pharmaceuticals

    Start SIP

    Pharmaids Pharmaceuticals Performance

    Day Range

    • Low 0
    • High 0
    ₹ 50

    52 Week Range

    • Low 0
    • High 0
    ₹ 50
    • Open Price0
    • Previous Close0
    • Volume

    Pharmaids Pharmaceuticals Share Price

    • Over 1 Month -11.89%
    • Over 3 Month -3.85%
    • Over 6 Month +2.71%
    • Over 1 Year +18.85%

    Pharmaids Pharmaceuticals Key Statistics

    Pharmaids Pharmaceuticals Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 00000
    Operating Expenses Qtr Cr 21129
    Operating Profit Qtr Cr -2-1-1-2-9
    Depreciation Qtr Cr 00000
    Interest Qtr Cr 00000
    Tax Qtr Cr 0-1-10-2
    Net Profit Qtr Cr -2-2-1-1-6
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 10
    Operating Expenses Annual Cr 610
    Operating Profit Annual in Cr -6-10
    Depreciation Cr 00
    Interest Annual Cr 00
    Tax Annual Cr -1-2
    Net Profit Annual Cr -5-8
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -3-4
    Cash from Investing Activity Annual Cr -73-5
    Cash from Financing Annual Activity Cr 6621
    Net Cash Flow Annual Cr 12
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 7122
    Fixed Assets Annual Cr 192
    Total Non Current Assets Annual Cr 807
    Total Current Assets Annual Cr 517
    Total Assets Annual Cr 8525
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 2010
    ROE Annual % -7-34
    ROCE Annual % -7-44
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % -20,0940
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 60000
    Operating Expenses Qtr Cr 111129
    Operating Profit Qtr Cr -6-1-1-2-9
    Depreciation Qtr Cr 10000
    Interest Qtr Cr 10000
    Tax Qtr Cr -1-1-10-2
    Net Profit Qtr Cr -6-2-1-1-6
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 160
    Operating Expenses Annual Cr 2810
    Operating Profit Annual in Cr -13-10
    Depreciation Cr 20
    Interest Annual Cr 20
    Tax Annual Cr -4-2
    Net Profit Annual Cr -8-8
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -11-4
    Cash from Investing Activity Annual Cr -75-5
    Cash from Financing Annual Activity Cr 7821
    Net Cash Flow Annual Cr -812
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 7222
    Fixed Assets Annual Cr 392
    Total Non Current Assets Annual Cr 787
    Total Current Assets Annual Cr 1418
    Total Assets Annual Cr 9125
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 2010
    ROE Annual % -11-34
    ROCE Annual % -18-44
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % -820
    Invest in Pharmaids Pharmaceuticals

    Pharmaids Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹50.00
    +0.49 (0.99%)
    pointer
    • Bullish Moving Average
    • ___
    • 1
    • Bearish Moving Average
    • ___
    • 15
    • 20 Day
    • ₹52.07
    • 50 Day
    • ₹53.98
    • 100 Day
    • ₹53.96
    • 200 Day
    • ₹49.72
    • 20 Day
    • ₹51.83
    • 50 Day
    • ₹55.44
    • 100 Day
    • ₹55.72
    • 200 Day
    • ₹51.02

    Pharmaids Pharmaceuticals Resistance and Support

    PIVOT
    ₹50.25
    Resistance
    First Resistance 51.44
    Second Resistance 52.99
    Third Resistance 54.18
    RSI 38.51
    MFI 42.68
    MACD Single Line -1.36
    MACD -1.50
    Support
    First Support 48.70
    Second Support 47.51
    Third Supoort 45.96

    Pharmaids Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 2,493 239,802 96.19
    Week 25,667 2,513,550 97.93
    1 Month 17,351 1,659,619 95.65
    6 Month 13,997 1,386,790 99.08

    Pharmaids Pharmaceuticals Result Highlights

    Pharmaids Pharmaceuticals Synopsis

    BSE-Medical-Diversified

    Pharmaids Pharma belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 21.44 Cr. for the Year ended 31/03/2023. Pharmaids Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 01/03/1989 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L52520KA1989PLC173979 and registration number is 173979.
    Market Cap 176
    Sales 0
    Shares in Float 3.32
    No of funds
    Yield
    Book Value 2.48
    U/D Vol ratio 2.5
    LTDebt / Equity 18
    Alpha 0.26
    Beta 0.46

    Pharmaids Pharmaceuticals Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 5.64%9.25%9.7%9.94%
    Individual Investors 41.06%60.78%81.93%81.28%
    Others 53.3%29.97%8.37%8.78%

    Pharmaids Pharmaceuticals Management

    Name Designation
    Mr. Venu Madhava Kaparthy Executive Director
    Ms. Mini Manikantan Executive Director
    Mr. Venkata Rao Sadhanala Non Exe.Non Ind.Director
    Mr. Mopperthy Sudheer Independent Director
    Mr. Methuku Nagesh Independent Director
    Mr. P N Vijay Independent Director

    Pharmaids Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Pharmaids Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-05-28 Audited Results
    2024-02-12 Quarterly Results
    2024-01-06 Preferential issue of shares
    2023-11-11 Quarterly Results
    2023-08-04 Quarterly Results

    Pharmaids Pharmaceuticals MF Shareholding

    Name Amount(cr)

    Pharmaids Pharmaceuticals FAQs

    What is Share Price of Pharmaids Pharmaceuticals ?

    Pharmaids Pharmaceuticals share price is ₹50 As on 01 July, 2024 | 06:31

    What is the Market Cap of Pharmaids Pharmaceuticals ?

    The Market Cap of Pharmaids Pharmaceuticals is ₹176.3 Cr As on 01 July, 2024 | 06:31

    What is the P/E ratio of Pharmaids Pharmaceuticals ?

    The P/E ratio of Pharmaids Pharmaceuticals is -19.7 As on 01 July, 2024 | 06:31

    What is the PB ratio of Pharmaids Pharmaceuticals ?

    The PB ratio of Pharmaids Pharmaceuticals is 2.5 As on 01 July, 2024 | 06:31

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.